New vaccine approaches for seasonal and pandemic influenza
- 1 November 2008
- Vol. 26 (49) , 6232-6236
- https://doi.org/10.1016/j.vaccine.2008.07.022
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responsesVaccine, 2007
- Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adultsVaccine, 2007
- Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: An international collaborative studyVaccine, 2007
- Influenza vaccination: policy versus evidenceBMJ, 2006
- Influenza vaccination: policy versus evidenceBMJ, 2006
- Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analysesVirus Research, 2004
- A “universal” human influenza A vaccineVirus Research, 2004
- Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?Virus Research, 2004
- Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patientsVaccine, 1997
- Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59Vaccine, 1995